Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

β-Lactam TRPM8 Antagonists Derived from Phe-Penylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity

Version 1 : Received: 1 September 2023 / Approved: 4 September 2023 / Online: 4 September 2023 (08:34:52 CEST)

A peer-reviewed article of this Preprint also exists.

Martín-Escura, C.; Bonache, M.Á.; Medina, J.A.; Medina-Peris, A.; De Andrés-López, J.; González-Rodríguez, S.; Kerselaers, S.; Fernández-Ballester, G.; Voets, T.; Ferrer-Montiel, A.; Fernández-Carvajal, A.; González-Muñiz, R. β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure–Activity Relationships and Antiallodynic Activity. Int. J. Mol. Sci. 2023, 24, 14894. Martín-Escura, C.; Bonache, M.Á.; Medina, J.A.; Medina-Peris, A.; De Andrés-López, J.; González-Rodríguez, S.; Kerselaers, S.; Fernández-Ballester, G.; Voets, T.; Ferrer-Montiel, A.; Fernández-Carvajal, A.; González-Muñiz, R. β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure–Activity Relationships and Antiallodynic Activity. Int. J. Mol. Sci. 2023, 24, 14894.

Abstract

The protein TRPM8, a non-selective, calcium (Ca2+) permeable ion channel is implicated in several pathological conditions, including neuropathic pain states. In our previous research endeavors, we have identified β–lactam derivatives with high hydrophobic character that exhibit potent and selective TRPM8 antagonist activity. This work describes the synthesis of novel derivatives featuring C-terminal amides and diversely substituted N’-terminal monobenzyl groups, in an attempt to increase the total polar surface area (TPSA) in this family of compounds. The primary goal was to assess the influence of these substituents on the inhibition of menthol-induced cellular Ca2+ entry, thereby establishing critical structure-activity relationships. While the substitution of the tert-butyl ester by isobutyl amide moieties improved the antagonist activity, none of the N’-monobencyl derivatives, regardless of the substituent on the phenyl ring, achieved the activity of the model dibenzyl compound. The antagonist potency of the most effective compounds was subsequently verified using Patch-Clamp electrophysiology experiments. Furthermore, we evaluated the selectivity of one of these compounds against other members of the TRP ion channel family and some receptors connected to peripheral pain pathways. This compound demonstrated specificity for TRPM8 channels. To better comprehend the potential mode of interaction, we conducted docking experiments to uncover plausible binding sites on the functionally active tetrameric protein, which come upon four main poses by the pore zone, differents from those described for other known antagonists. Finally, in vivo experiments, involving a couple of selected compounds, revealed significant antinociceptive activity within a mice model of cold allodynia induced by oxaliplatin.

Keywords

TRPM8 channel; β–lactams; antagonists; docking; antinociceptive activity

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.